Results 41 to 50 of about 62,039 (256)
Jornal de Assistência Farmacêutica e Farmacoeconomia, 2023 Objective: The aim of this study is to identify the prevalence of drug interaction associated with proton pump inhibitors, associated factors and drugs involved.
Lorena Maria Lima de Araujo +5 more
doaj +1 more source
Arthritis Care &Research, EarlyView.Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin +14 more
wiley +1 more source
Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
Italian Journal of Medicine, 2015 Proton pump inhibitors (PPIs) are the most potent drugs for reducing gastric acid secretion; so, since their release in the late 1980s, they have been recommended as the first therapeutic choice for many gastroesophageal diseases, risk reduction in or ...
Mario Visconti
doaj +1 more source
Do proton pump inhibitors affect the biomechanical efficiency of implant?- a systematic review
Journal of Oral Biology and Craniofacial Research, 2022 -: Purpose: This systematic review was executed to determine the influence of proton pump inhibitors on biomechanical efficiency of dental implants. Materials and methods: The comprehensive online literature search was conducted on digital database of ...
Varsha Verma
doaj +1 more source
Handbook of Establishing and Maintaining Oxygen‐Free Atmospheres
Advanced Engineering Materials, EarlyView.This study presents a practical framework for creating oxygen‐free atmospheres at ambient pressure using silane‐doped inert gases. The results show that ultra‐low oxygen levels and strongly reduced water content can be achieved through controlled silane dosing, drying systems, and sensor monitoring.
Sascha Jan Zimmermann +3 more
wiley +1 more source
Antiplatelet agents and proton pump inhibitors – personalizing treatment
Pharmacogenomics and Personalized Medicine, 2010 Eugene Lin, Rajiv Padmanabhan, Majaz MoonisDepartment of Neurology, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USAIntroduction: Antiplatelet therapy remains one of the cornerstones in the ...
Eugene Lin +2 more
doaj
Advanced Healthcare Materials, EarlyView.Coagulative granular hydrogels are composed of packed thrombin‐functionalized microgels that catalyze the conversion of fibrinogen into a secondary fibrin network, filling the interstitial voids. This bio‐inspired approach stabilizes the biomaterial to match the robustness of bulk hydrogels without compromising injectability, mimicking the initial ...
Zhipeng Deng +16 more
wiley +1 more source
Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
International Journal of Molecular Sciences, 2023 Protein molecular machines, also known as proton pumps, are the most important element of biological membranes [...]
openaire +2 more sources
PLoS ONE, 2020 ObjectivesThe purpose of this study was to reconfirm the association between the risk of fracture and proton pump inhibitor use and to establish evidence for defining a high-risk group of patients among proton pump inhibitor users.MethodsA nested case ...
Jong Joo Kim +3 more
doaj +1 more source
Comparison of Proton Pump Inhibitor and Triple Therapy Regimen for Laryngospharyngeal Reflux Disease
Journal of Nepal Health Research Council, 2020 Background: Laryngopharyngeal reflux is retrograde flow of contents of the stomach to the larynx and the pharynx. The study aims to compare two regimens (proton pump inhibitor monotherapy versus triple therapy) on the outcome of Helicobactor pylori ...
Apar Pokharel +2 more
doaj +1 more source